21-Gene recurrence scores : Racial differences in testing, scores, treatment, and outcome

Association between standard clinical an

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients : A population-based study

✍ Ido Wolf; Noa Ben-Baruch; Ronnie Shapira-Frommer; Shulamit Rizel; Hadassa Goldbe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

## Abstract ## BACKGROUND. The 21‐gene recurrence score (RS) assay has been reported to accurately predict the risk of disease recurrence and chemotherapy benefit in women with estrogen receptor (ER)‐positive, lymph node (LN)‐negative breast cancer who are treated with tamoxifen. To the authors' k